|
Synonyms: Kepivance® | keratinocyte growth factor
palifermin is an approved drug (FDA (2004), EMA (2005))
Compound class:
Peptide
Comment: Palfermin is a modified truncated form of human keratinocyte growth factor produced by recombinant DNA technology.
|
Classification  |
|
| Compound class | Peptide |
| Approved drug? | Yes (FDA (2004), EMA (2005)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 8186 | palifermin |
| Synonyms |
| Kepivance® | keratinocyte growth factor |
| Database Links |
|
| CAS Registry No. | 162394-19-6 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL1201821 |
| DrugBank Ligand | DB00039 |
| GtoPdb PubChem SID | 178103536 |
| PubChem SID | 135252604 |
| Search PubMed clinical trials | palifermin |
| Search PubMed titles | palifermin |
| Search PubMed titles/abstracts | palifermin |
| Wikipedia | Palifermin |
